Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease.

Details

Language :

English

ISSN :

18739946

Volume :

12

Issue :

9

Database :

Complementary Index

Journal :

Journal of Crohn's & Colitis

Publication Type :

Academic Journal

Accession number :

131555114

Full Text :

https://doi.org/10.1093/ecco-jcc/jjy049